Literature DB >> 3649232

Evaluation of PAF antagonists using human neutrophils in a microtiter plate assay.

B Dewald, M Baggiolini.   

Abstract

This paper describes a testing model for the detection and evaluation of PAF antagonists, based on the inhibition of PAF-elicited elastase release by human neutrophils. Incubations are performed in microtiter plates in the presence of a specific fluorogenic elastase substrate allowing direct measurement of the exocytosis response by means of a 96-well fluorescence reader. Determinations of the IC50 values for five established PAF antagonists, Ro 19-3704, BN 52021, CV-3988, 48740 RP and kadsurenone, showed that the new model is comparable in sensitivity and discriminative capacity to other in vitro assays. From the effect of antagonists on the PAF concentration-response curve pA2 values could be calculated and information on the type of antagonism obtained. BN 52021 was found to behave as a competitive antagonist while Ro 19-3704 showed a more complex type of inhibition. As a one-plate system, the test is simple to handle and highly reproducible, and appears therefore particularly useful for large drug screening programs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3649232     DOI: 10.1016/0006-2952(87)90523-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

Review 1.  Cellular models for the detection and evaluation of drugs that modulate human phagocyte activity.

Authors:  M Baggiolini; B Dewald
Journal:  Experientia       Date:  1988-10-15

2.  Staurosporine inhibits the respiratory burst and induces exocytosis in human neutrophils.

Authors:  B Dewald; M Thelen; M P Wymann; M Baggiolini
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

3.  Bovine ENA, a new monocyte-macrophage derived cytokine of the interleukin-8 family. Structure, function, and expression in acute pulmonary inflammation.

Authors:  I Allmann-Iselin; B D Car; R D Zwahlen; R Mueller-Schüpbach; M Wyder-Walther; U Steckholzer; A Walz
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

4.  Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

Authors:  L M Webb; M U Ehrengruber; I Clark-Lewis; M Baggiolini; A Rot
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

5.  Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. The special case of Streptococcus pneumoniae.

Authors:  C Cabellos; D E MacIntyre; M Forrest; M Burroughs; S Prasad; E Tuomanen
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

6.  Influence of a platelet-activating factor antagonist on severe pancreatitis in two experimental models.

Authors:  U Leonhardt; A Fayyazzi; F Seidensticker; F Stöckmann; H D Söling; W Creutzfeldt
Journal:  Int J Pancreatol       Date:  1992-10

7.  Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis.

Authors:  M Seitz; B Dewald; N Gerber; M Baggiolini
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

8.  Differential inhibition by nedocromil sodium of superoxide generation elicited by platelet activating factor in human neutrophils.

Authors:  R P Rubin; R H Thompson; M S Naps
Journal:  Agents Actions       Date:  1990-11

9.  A novel neutrophil-activating factor produced by human mononuclear phagocytes.

Authors:  P Peveri; A Walz; B Dewald; M Baggiolini
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

10.  Apoptotic neutrophils undergoing secondary necrosis induce human lung epithelial cell detachment.

Authors:  Chien-Ying Liu; Yun-Hen Liu; Shu-Min Lin; Chih-Ten Yu; Chun-Hua Wang; Horng-Chyuan Lin; Chien-Huang Lin; Han-Pin Kuo
Journal:  J Biomed Sci       Date:  2003 Nov-Dec       Impact factor: 8.410

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.